Serum Levels of Interleukin 18 and Interleukin 10 in Iranian Patients with Bullous Pemphigoid and Their Correlation with BP180-NC16a and BP230

  • Nafisseh Esmaili Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran AND Autoimmune Bullous Research Center, Tehran University of Medical Sciences, Tehran, Iran
  • Hossein Mortazavi Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran AND Autoimmune Bullous Research Center, Tehran University of Medical Sciences, Tehran, Iran
  • Mahshid Sadat Ansari Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
  • Maryam Nasimi Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
  • Yasaman Ardalanrad Mail Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
  • Amir Teimourpour Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Keywords:
Keywords

Abstract

Absracts Absracts Absracts Absracts Absracts 

References

1. Antiga E, Quaglino P, Volpi W, Pierini I, Del Bianco E, Bianchi B, et al. Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid. J Eur Acad Dermatol Venereol 2014; 28(2):222-30.
2. Fang H, Shao S, Cao T, Lei J, Dang E, Zhang J, et al. Increased expression of NLRP3 inflammasome components and interleukin-18 in patients with bullous pemphigoid. J Dermatol Sci 2016; 83(2):116-23.
3. Kowalski E, Kneibner D, Kridin K, Amber K. Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid. Autoimmun Rev 2019, 18(5):526-34.
4. Mortazavi H, Esmaili N, Khezri S, Khamesipour A, Farahani IV, Daneshpazhooh M, et al. The effect of conventional immunosuppressive therapy on cytokine serum levels in pemphigus vulgaris patients. Iran J Allergy Asthma Immunol 2014; 13(3):174-83.
5. Liu Z, Dang E, Li B, Qiao H, Jin L, Zhang J, et al. Dysfunction of CD19+ CD24 hi CD27+ B regulatory cells in patients with bullous pemphigoid. Sci Rep 2018; 8(1):703.
6. Rao CV. Immunology: Alpha Science International Limited; 2016.
7. Esmailbeig M, Ghaderi AJEcn. Interleukin-18: a regulator of cancer and autoimmune diseases. Eur Cytokine Netw 2017; 28(4):127-40.
8. Liu Y, Li L, Xia YJFii. BP180 is critical in the autoimmunity of bullous pemphigoid. Front Immunol 2017; 8:1752.
9. Nakama K, Koga H, Ishii N, Ohata C, Hashimoto T, Nakama T. Clinical and Immunological Profiles of 14 Patients With Bullous Pemphigoid Without IgG Autoantibodies to the BP180 NC16A Domain. JAMA Dermatol 2018; 154(3):347-50.
10. Sun X-K, Chen J-F, Shen HJAodr. Immunohistochemical study of toll-like receptors 2, 4, and 9 expressions in pemphigus and bullous pemphigoid lesions. Arch Dermatol Res 2016; 308(6):429-36.
Published
2020-02-01
How to Cite
1.
Esmaili N, Mortazavi H, Ansari MS, Nasimi M, Ardalanrad Y, Teimourpour A. Serum Levels of Interleukin 18 and Interleukin 10 in Iranian Patients with Bullous Pemphigoid and Their Correlation with BP180-NC16a and BP230. Iran J Allergy Asthma Immunol. 19(1):102-104.
Section
Letter to the Editor